Endocare and Former CEO Paul W. Mikus Agree to Terminate Indemnification Agreement
Endocare CFO Michael R. Rodriguez said, "This agreement brings to a closeour indemnification of former management and a long, expensive chapter forEndocare. It finally and immediately ends what has been a significant expenseand allows management to focus more completely on building our business."
Endocare had previously announced a similar agreement with its former CFO.For more information regarding the agreement with Mr. Mikus, please see therelated Form 8-K filed by Endocare today with the Securities and ExchangeCommission.
Endocare, Inc. -- http://www.endocare.com -- is an innovative medicaldevice company focused on the development of minimally invasive technologiesfor tissue and tumor ablation. Endocare has initially concentrated ondeveloping technologies for the treatment of prostate cancer and believes thatits proprietary technologies have broad applications across a number ofmarkets, including the ablation of tumors in the kidney, lung and liver andpalliative intervention (treatment of pain associated with metastases).Investor Contact: Media Contact: Matt Clawson Len Hall Allen & Caron, Inc. Allen & Caron, Inc. (949) 474-4300 (949) 474-4300 firstname.lastname@example.org email@example.com http://www.allencaron.com http://www.allencaron.com For Additional Information: Terrence A. Noonan, Interim CEO Michael R. Rodriguez, CFO Endocare, Inc. (949) 450-5400 http://www.endocare.com
SOURCE Endocare, Inc.
You May Also Like